- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Intraepithelial Neoplasia in Australia
Total 4874 results
-
Life Molecular Imaging SATerminatedProstate CancerAustria, Finland
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
St Vincent's Hospital, SydneyClarity Pharmaceuticals LtdCompleted
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
Medical University of GrazTerminatedProstate Cancer | Radiotherapy Side EffectAustria
-
Pellficure Pharmaceuticals, IncTerminatedProstate CancerUnited States, Australia
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
Medical University of ViennaRecruiting
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
Medical University of ViennaWithdrawnProstate CancerAustria
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
St Vincent's Hospital, SydneyCompleted
-
Life Molecular Imaging SACompleted
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Melbourne HealthAustin Health; Peter MacCallum Cancer Centre, Australia; St Vincent's Hospital; Epworth HealthcareNot yet recruitingProstate Cancer | Learning Curve | Patient Reported Outcome Measures | Oncological Outcomes | Database | Robotic-assisted Radical Prostatectomy | Surgical OutcomesAustralia
-
Antiva BiosciencesRecruitingCervical Intraepithelial NeoplasiaAustralia, South Africa
-
Medical University of ViennaRecruiting
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Medical University of ViennaBSM Diagnostica GmbH Vienna; Siemens Healthcare GmbHCompleted
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
Inovio PharmaceuticalsCompletedCervical Intraepithelial NeoplasiaSouth Africa, United States, Korea, Republic of, Canada, Estonia, India, Georgia, Australia, Puerto Rico
-
Lawson Health Research InstituteCompletedProstate CancerUnited Kingdom, Australia, Canada
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Medical University of GrazCompletedInflammation | Prostate Cancer | Radiotherapy; Complications | Aging DisorderAustria
-
University of MiamiJay L. Friedland MD Prostate Cancer Research FundRecruitingProstate CancerUnited States, Australia, Italy
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
Medical University of ViennaCompletedBarrett's Mucosa With High Grade Intraepithelial Neoplasia (HGIEN)Austria
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Nuvation Bio Inc.RecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Breast Carcinoma | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Cancer of the Ovary | Pancreas Cancer | Triple-negative Breast Cancer | Cancer of Pancreas | Pancreas Neoplasm | Prostate Neoplasm | Cancer... and other conditionsUnited States, Australia
-
Clarity Pharmaceuticals LtdCompleted
-
European Organisation for Research and Treatment...CompletedProstate CancerUnited Kingdom, Netherlands, Denmark, Belgium, Norway, France, Australia, Germany, Italy, Turkey, Romania
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria